엑스바이오텍(XBIT)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $2.30 (-1.29%), 시가총액 $0.08B, 52주 범위 $2.12 ~ $3.50.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
엑스바이오텍의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
엑스바이오텍의 현재 주가는 $2.30 (-1.29%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
엑스바이오텍의 시가총액은 약 $0.08B입니다.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory